102 related articles for article (PubMed ID: 25427044)
1. New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma.
Zhang XM; Aguilera N
Arch Pathol Lab Med; 2014 Dec; 138(12):1666-72. PubMed ID: 25427044
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
[TBL] [Abstract][Full Text] [Related]
3. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
4. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
5. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
6. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
[TBL] [Abstract][Full Text] [Related]
7. Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphoma.
Dewar R; Andea AA; Guitart J; Arber DA; Weiss LM
Arch Pathol Lab Med; 2015 Mar; 139(3):338-50. PubMed ID: 25724031
[TBL] [Abstract][Full Text] [Related]
8. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
Kovrigina AM; Probatova NA
Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved?
Pervez S; Khawaja RD
Pathol Res Pract; 2010 Jun; 206(6):365-7. PubMed ID: 20185248
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Algorithm of Common Mature B-Cell Lymphomas by Immunohistochemistry.
Wang HY; Zu Y
Arch Pathol Lab Med; 2017 Sep; 141(9):1236-1246. PubMed ID: 28608720
[TBL] [Abstract][Full Text] [Related]
11. A practical approach to the diagnosis of Hodgkin lymphoma.
Listinsky CM
Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
[TBL] [Abstract][Full Text] [Related]
12. Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
Oertel J; Kingreen D; Busemann C; Stein H; Dörken B
J Cancer Res Clin Oncol; 2002 Apr; 128(4):182-8. PubMed ID: 11935308
[TBL] [Abstract][Full Text] [Related]
13. Diffuse aggressive B-cell lymphomas.
Said J
Adv Anat Pathol; 2009 Jul; 16(4):216-35. PubMed ID: 19546610
[TBL] [Abstract][Full Text] [Related]
14. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
15. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
16. Pathology of B-cell lymphomas: diagnosis and biomarker discovery.
Ondrejka SL; Hsi ED
Cancer Treat Res; 2015; 165():27-50. PubMed ID: 25655605
[TBL] [Abstract][Full Text] [Related]
17. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases.
Plaza JA; Kacerovska D; Sangueza M; Schieke S; Buonaccorsi N; Suster S; Kazakov DV
Am J Dermatopathol; 2014 Jun; 36(6):478-82. PubMed ID: 24698933
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of multiparametric flow cytometry in detecting composite lymphoma: study of 17 cases in a 12-year period.
Demurtas A; Aliberti S; Bonello L; Di Celle PF; Cavaliere C; Barreca A; Novero D; Stacchini A
Am J Clin Pathol; 2011 Apr; 135(4):541-55. PubMed ID: 21411776
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
Linder J; Ye Y; Armitage JO; Weisenburger DD
Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
